1. Al-Adawi S, Dorvlo AS, Burke DT, Moosa S, Al-Bahlani S. A survey of anorexia nervosa using Arabic version of the EAT- 26 and “gold standard” interviews among Omani ado lescents. Eat Weight Disord 2002; 7 (4): 304–11.
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. TR (DSM-4). Washing ton, DC: American Psychiatric Publishing; 2000.
3.
Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007; 61:551–553.
4.
Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linszen DH. Significantly reduced docosahexaeno ic and docosapentaenoic acid concentrations in erythro cyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001;49:510–522.
5.
Austin GL, Ogden LG, Hill JO. Trends in carbohydrate, fat, and protein intakes and association with energy inta ke in normal-weight, overweight, and obese individuals: 1971-2006. Am J Clin Nutr. 2011; 93(4): 836–43.
6.
Ayton AK, Azaz A, Horrobin DF. Rapid improvement of se vere anorexia nervosa during treatment with ethyl-eico sapentaenoate and micronutrients. Eur Psychiatry 2004; 19(5): 317–9 (a).
7.
Ayton AK, Azaz A, Horrobin DF. A pilot open case series of Ethyl- EPA supplementation in the treatment of anorexia nervosa. Prostaglandins Leukot Essent Fatty Acids.2004; 71(4): 205–209 (b).
8.
Barragan E, Breuer D, Dopfner M. Efficacy and safety of ome ga 3/6 fatty acids, methylphenidate, and a combined treat ment in children with ADHD. J Atten Disorder. Jan, 24, 2014.
9.
Bech P. Scale for assessment of diagnosis and severi ty of mental disorders. Acta Psychiatr. Scand. 1993, 87, suppl. 372.
10.
Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disor der: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot. Essent. Fatty Acids. 2000; 63:21–25
11.
Burgess JR, Stevens L, Zhang W, Peck L. Long-chain poly unsaturated fatty acids in children with attention-de ficit hyperactivity disorder. Am J Clin Nutr. 2000; 71: 327S–330S.
12.
Caspar-Bauguil S, Montastier E, Galinon F, Frisch-Benarous D, Salvayre R, Ritz P. Anorexia nervosa patients display a de ficit in membrane long chain poly-unsaturated fatty acids. Clin Nutr. 2012 Jun; 31(3): 386–90.
13.
Constaín GA, Ricardo Ramírez C, Rodríguez-Gázquez Mde L, Alvarez Gómez M, Marín Múnera C, Agudelo Acosta C. Diagnostic validity and usefulness of the Eating Attitudes Test-26 for the assessment of eating disorders risk in a Co lombian female population. Aten Primaria. 2014; 46 (6): 283–9.
14.
Damsbo-Svendsen S, Rønsholdt MD, Lauritzen L. Fish-oil supplementation increases appetite in healthy adults. A ran domized controlled cross-over trial. Appetite. 2013; 66: 62–6.
15.
Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M. A placebo-controlled trial of omega-3 fatty acid (ethyl eico sapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry. 2001; 158: 2071–2074.
16.
Fraguas D, Díaz-Caneja CM, Pina-Camacho L, Moreno C, Durán-Cutilla M, Ayora M, González-Vioque E, de Matteis M, Hendren RL, Arango C, Parellada M. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis. Pediatrics 2019 Nov; 144(5).
17.
Garner DM, Olmsted MP, Bohr Y, Garnfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med. 1982 nov; 12(4): 871–8.
18.
Gauthier C, Hassler C, Mattar L, Launay JM, Calleebert J, Steiger H, Melchior JC, Fallisard B, Berthoz S, Mourier-So leillant V, Lang F, Delorme M, Pommereau X, Gererdin P, Bioulac; EHVAN Group, Godart N. Symptoms of depression and anxiety in anorexia nervosa: links with plasma trypto phan and serotonin metabolism. Psychoneuroendocrinology. 2014; 39: 170–8.
19.
Gopalan Y, Shuaib IL, Magosso E, Ansari MA, Abu Bakar MR, Wong JW, Khan NA, Liong WC, Sundram K, Ng BH, Karuthan C, Yuen KH. Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter. Stroke. 2014; 45(5): 1422–8.
20.
Keck PE, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006; 60: 1020–1022.
21.
Kraeft JJ, Uppot RN, Heffess AM. Imaging findings in eating disorders. AJR Am J Roentgenol. 2013; 200(4): W328–W335.
22.
Kunesová M, Braunerová R, Hlavatý P, Tvrzická E, Stanková B, Skrha J, Hilgertová J, Hill M, Kopecký J, Wagenknecht M, Hainer V, Matoulek M, Parízková J, Zák A, Svacina S. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res. 2006; 55 (1): 63–72.
23.
Ladeia AM, Costa-Matos E, Barata-Passos R, Costa Guimares A. A palm oil-rich diet may reduce serum lipids in healthy young individuals. Nutrition. 2008; 24(1): 11–5.
24.
Lock J, La Via MC. American Academy of Child and Ado lescent Psychiatry (AACAP) Committee on Quality Issue(CQI). Practice parameter for the assessment and treatment of children and adolescents with eating disorders AACAP 2015. J. Am. Acad. Child. Adolesc. Psychiatry. 2015 May; 54(5): 412–25.
25.
Manos BE, Bravender TD, Harrison TM, Lange HLH, Cottrill CB, Abdel-Rasoul M,Bonny AE. A pilot randomized contro lled trial of omega-3 fatty acid supplementation for the tre atment of anxiety in adolescents with anorexia nervosa. Int J Eat Disord. 2018 Dec; 51(12): 1367–1372.
26.
Matzkin VB, Geissler C, Coniglio R, Selles J, Bello M. Chole sterol concentration in patient with anorexia nervosa and in healthy controls. Int J Psychiatr Nurs Res. 2006; 11(2): 1283–93.
27.
McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psy chiatry. 2007; 62: 17–24.
28.
McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pan dey GN. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord: 1573-2517, 2010; Vol. 126 (1–2): 303–311.
29.
Micallef M, Munro I, Phang M, Garg M. Plasma n-3 Poly unsaturated Fatty Acids are negatively associated with obe sity. Br J Nutr. 2009; 102 (9): 1370–4.
30.
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker R. H. Ome ga-3 treatment of childhood depression: A controlled, double blind pilot study. Am J Psychiatry 2006; 163: 1098–1100.
31.
Parra D, Ramel A, Bandarra N, Kiely M, Martínez JA, Thor sdottir I. A diet rich in long chain omega-3 fatty acids mo dulates satiety in overweight and obese volunteers during weight loss. Appetite. 2008; 51(3): 676–80.
32.
Patsalos O, Mavrogiannidis T, Dalton B, Field CJ, Himmerich H. Phosphatidylcholine Containing Long Chain Omega-3 Fatty Acids: a Treatment Adjunct for Patients with Anorexia Nervosa? Psychiatr Danub. 2020 Spring; 32(1): 55–59.
33.
Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002; 59: 913–919.
34.
Practice guideline for the treatment of patients with eating disorders , 3rd edition, APA Practice Guideline.
35.
Richardson AJ, Montgomery P. The Oxford-Durham study: a randomised, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 2005; 115: 1360–1366.
36.
Richardson AJ, Puri BK. A randomised double-blind, place bo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuro--Psychopharmacog Biol Psychiatry 2002; 26: 233–239.
37.
Roberts ME, Tchanturia K, Treasure JL. Is attention to detail a similarly strong candidate endophenotype for anorexia nervosa and bulimia nervosa? World J. Biol. Psychiatry 2013; 14(6): 452–463.
38.
Ross BM. Omega-3 fatty acid deficiency in major depressi ve disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid me tabolism. Med Hypotheses. 2007; 68: 515–524.
39.
Sinn N, Bryan J. Effect of supplementation with polyunsa turated fatty acids and micronutrients on ADHD-related problems with attention and behavior. J Dev Behav Pediatr 2007; 28: 82–9162.
40.
Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante CM. Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2008; 69: 644–651.
41.
Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial. Eu. Neuropsychopharmacol. 2003; 13: 267–271.
42.
Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging. 2002; 23: 843–853.
43.
Żechowski C, Namysłowska I, Jakubczyk A., Siewierska A, Bażyńska AK. Program leczenia zaburzeń odżywiania w oddziale psychiatrycznym dla młodzieży – refleksje i dy lematy po 20 latach doświadczeń. Psychiatr. Psychol. Klin. 2010, 10(1), 25–30.
